Trial Profile
Efficacy of bosentan in patients with pulmonary hypertension due to valvular heart disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 07 Dec 2015 New trial record